Synthesis and SAR of potent EGFR/erbB2 dual inhibitors
…, SB Guntrip, D Rusnak, K Smith, D Vanderwall…
Index: Zhang, Yue-Mei; Cockerill, Stuart; Guntrip, Stephen B.; Rusnak, David; Smith, Kathryn; Vanderwall, Dana; Wood, Edgar; Lackey, Karen Bioorganic and Medicinal Chemistry Letters, 2004 , vol. 14, # 1 p. 111 - 114
Full Text: HTML
Citation Number: 52
Abstract
A series of 6-alkoxy-4-anilinoquinazoline compounds was prepared and evaluated for in vitro inhibition of the erbB2 and EGFR kinase activity. The IC50 values of the best compounds were below 0.10 uM. Further, several of these compounds inhibit the growth of erbB2 and EGFR over-expressing tumor cell lines at concentrations below 1 uM.
Related Articles:
[Mao, Yongjun; Zhu, Wenxiu; Kong, Xiaoguang; Wang, Zhen; Xie, Hua; Ding, Jian; Terrett, Nicholas Kenneth; Shen, Jingkang Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 11 p. 3090 - 3104]
[Petrov, Kimberly G.; Zhang, Yue-Mei; Carter, Malcolm; Cockerill, G. Stuart; Dickerson, Scott; Gauthier, Cassandra A.; Guo, Yu; Mook Jr., Robert A.; Rusnak, David W.; Walker, Ann L.; Wood, Edgar R.; Lackey, Karen E. Bioorganic and Medicinal Chemistry Letters, 2006 , vol. 16, # 17 p. 4686 - 4691]